59 results
Page 3 of 3
424B3
v9t0v tmazb
9 Jun 21
Prospectus supplement
4:42pm
8-K
EX-99.1
njotn1
4 Jun 21
POINT Biopharma Announces First Patients
4:22pm
425
EX-99.1
pu1sj4e4
4 Jun 21
Business combination disclosure
4:20pm
8-K
EX-99.1
7xe03qp
1 Jun 21
POINT Biopharma Receives U.S. Nuclear Regulatory Commission Materials License for Indiana Facility
4:32pm
8-K
rszk4jucjtk9qg9v
1 Jun 21
POINT Biopharma Receives U.S. Nuclear Regulatory Commission Materials License for Indiana Facility
4:32pm
425
EX-99.1
lcu5c o5e0w
1 Jun 21
Business combination disclosure
4:30pm
425
k3r0hbjj
1 Jun 21
Business combination disclosure
4:30pm
S-4/A
EX-10.19
oicg09vft jl
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
zm9g4 7z5
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.16
norml linza76br0
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
8-K
gbr9q k42wsbq2fvsnde
28 Apr 21
POINT Biopharma Receives U.S. Nuclear Regulatory Commission Materials License for Indiana Facility
5:13pm
8-K
EX-99.1
6n096ltwwy90viyma
28 Apr 21
POINT Biopharma Receives U.S. Nuclear Regulatory Commission Materials License for Indiana Facility
5:13pm
425
gb6pp42 uq5cgd
28 Apr 21
Business combination disclosure
5:11pm
425
EX-99.1
o7bgp 51m4qt
28 Apr 21
Business combination disclosure
5:11pm
S-4
c3dszras2nus9 dcapy
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.16
ryb9gy
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm